| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/5584_2017_141 |
| P698 | PubMed publication ID | 29270885 |
| P50 | author | András Dinnyés | Q31093798 |
| Julianna Kobolák | Q55873524 | ||
| P2093 | author name string | Ali Mobasheri | |
| Zsuzsanna Táncos | |||
| Cormac Murphy | |||
| P2860 | cites work | Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes | Q24670233 |
| Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a review | Q26745714 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment | Q28272235 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Basic science of articular cartilage and osteoarthritis | Q28301393 | ||
| Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II | Q28396036 | ||
| Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes | Q28505614 | ||
| Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors | Q29247925 | ||
| Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue | Q29620725 | ||
| Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. | Q50495137 | ||
| Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. | Q50734388 | ||
| Differential Regulation of SOX9 Protein During Chondrogenesis of Induced Pluripotent Stem Cells Versus Mesenchymal Stromal Cells: A Shortcoming for Cartilage Formation. | Q51500622 | ||
| Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. | Q51794075 | ||
| Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. | Q51852822 | ||
| Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations | Q33561564 | ||
| Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink | Q33674174 | ||
| Developing bones are differentially affected by compromised skeletal muscle formation. | Q33812822 | ||
| Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. | Q33862395 | ||
| Cell biology of osteoarthritis: the chondrocyte's response to injury | Q34439709 | ||
| Cell-based articular cartilage repair: the link between development and regeneration | Q35118299 | ||
| Connexin43 enhances the expression of osteoarthritis-associated genes in synovial fibroblasts in culture | Q35511112 | ||
| Improved approach for chondrogenic differentiation of human induced pluripotent stem cells | Q35546995 | ||
| TGF-beta signaling is essential for joint morphogenesis. | Q36118640 | ||
| Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis. | Q36183609 | ||
| Repair and tissue engineering techniques for articular cartilage | Q36239532 | ||
| Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. | Q36436781 | ||
| A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration | Q37117718 | ||
| The epidemiology and impact of pain in osteoarthritis | Q37121928 | ||
| Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint. | Q37516927 | ||
| Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model | Q37671213 | ||
| Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis | Q37692561 | ||
| The impact of osteoarthritis in the United States: a population-health perspective: A population-based review of the fourth most common cause of hospitalization in U.S. adults | Q37996829 | ||
| Pluripotent stem cells progressing to the clinic | Q38747535 | ||
| Induced pluripotent stem cells in cartilage repair | Q38891605 | ||
| Generation of scaffoldless hyaline cartilaginous tissue from human iPSCs. | Q38904482 | ||
| Induced pluripotent stem cell technology: a decade of progress | Q39040578 | ||
| Chondrogenic differentiation of human pluripotent stem cells in chondrocyte co-culture | Q39144046 | ||
| Chondrocytes Derived From Mesenchymal Stromal Cells and Induced Pluripotent Cells of Patients With Familial Osteochondritis Dissecans Exhibit an Endoplasmic Reticulum Stress Response and Defective Matrix Assembly. | Q41261563 | ||
| Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts | Q41980314 | ||
| Aging and osteoarthritis | Q42011299 | ||
| Reprogramming of Dermal Fibroblasts into Osteo-Chondrogenic Cells with Elevated Osteogenic Potency by Defined Transcription Factors. | Q42154450 | ||
| Induction of chondrogenesis from human embryonic stem cells without embryoid body formation by bone morphogenetic protein 7 and transforming growth factor beta1. | Q42463730 | ||
| Effects of immobilization on fetal bone development. A morphometric study in newborns with congenital neuromuscular diseases with intrauterine onset | Q45185937 | ||
| Final results of a phase I-II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration | Q47852500 | ||
| The importance of timing differentiation during limb muscle development | Q47946125 | ||
| Connexin43 Mutant Patient-Derived Induced Pluripotent Stem Cells Exhibit Altered Differentiation Potential | Q48263130 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoarthritis | Q62736 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 55-68 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | The Potency of Induced Pluripotent Stem Cells in Cartilage Regeneration and Osteoarthritis Treatment | |
| P478 | volume | 1079 |
| Q55202160 | Combating Osteoarthritis through Stem Cell Therapies by Rejuvenating Cartilage: A Review. | cites work | P2860 |
Search more.